Compare BEAM & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEAM | USAS |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.2B |
| IPO Year | 2019 | 2004 |
| Metric | BEAM | USAS |
|---|---|---|
| Price | $26.08 | $8.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 2 |
| Target Price | ★ $49.13 | $4.08 |
| AVG Volume (30 Days) | 1.7M | ★ 6.3M |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,000.00 | N/A |
| Revenue This Year | N/A | $26.21 |
| Revenue Next Year | $35.80 | $129.30 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $13.53 | $0.40 |
| 52 Week High | $36.44 | $10.50 |
| Indicator | BEAM | USAS |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 52.06 |
| Support Level | $23.84 | $6.67 |
| Resistance Level | $29.06 | $8.66 |
| Average True Range (ATR) | 1.96 | 0.64 |
| MACD | -0.19 | -0.12 |
| Stochastic Oscillator | 14.79 | 36.15 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.